Publisher
Springer Berlin Heidelberg
Reference25 articles.
1. Alanen YO, Räkköläinen V, Laakso J (1982) Krankheitsmodelle bei der Schizophrenie und die Bedürfnisangemessenheit der Behandlung. Nervenarzt 53:150–153
2. Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA (1984) Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. Acta Psychiat Scand 69:49 – 74
3. Baldessarini RJ, Davis JM (1980) What is the best maintenance dose of neuroleptics in schizophrenia? Psychiat Res 3:115 – 122
4. Baldessarini RJ, Cohen BM, Teicher MH (1988) Significance of neuroleptic dose and plasma level in the pharmacologic treatment of psychoses. Arch Gen Psychiatry 45:79 – 91
5. Bigelow LB, Kirch DG, Braun T, Korpi ED, Wagner RL, Zalcman S, Wyatt RJ (1985) Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: A fixed-dose study. Psychopharmacol Bull 21:66 – 68